+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global dPCR & qPCR Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical Application, Forensic Applications, Research Application), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 189 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5367883
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The dPCR & qPCR Market grew from USD 8.05 billion in 2023 to USD 8.88 billion in 2024. It is expected to continue growing at a CAGR of 10.23%, reaching USD 15.94 billion by 2030.

Quantitative PCR (qPCR), also known as real-time PCR, is a technique that enables the continuous monitoring of the PCR reaction as it progresses. It involves using fluorescent reporter molecules to quantify the amount of amplified nucleic acids in real-time. dPCR and qPCR enable rapid DNA amplification and quantification necessary for a wide range of applications, including genotyping, gene expression analysis, viral load determination, and validation of high-throughput sequencing data. The rising prevalence of infectious diseases has necessitated the deployment of advanced diagnostics procedures to ensure fast and efficient disease detection. Increased funding for genomics research projects from public & private organizations and the growing need for personalized diagnostics and therapeutic options has further boosted the adoption of PCR technologies. However, the initial investment for acquiring advanced instrumentation required for PCR can be a significant economic barrier for some organizations. Furthermore, analyzing high-dimensional data generated by dPCR & qPCR experiments requires specialized bioinformatics tools & the lack of expertise might impede the widespread adoption of dPCR and qPCR. Efforts by the government and established players to expand access to training programs for PCR technology can overcome such challenges. Technological advancements in PCR technologies and continuous research & development efforts have expanded the growth of dPCR and qPCR technology.

Regional Insights

In the Americas region, the demand for dPCR and qPCR is driven primarily by advancements in life sciences research, diagnostics, and pharmacogenomics. The United States has a well-established pharmaceutical industry that invests heavily in research & development activities. A strong focus on precision medicine initiatives also contributes to increased adoption. In Europe, there is an increasing number of diagnostic centers that frequently utilize advanced PCR technologies. Germany, France, and the UK also invest heavily in molecular diagnostics. Higher government spending on healthcare infrastructure and stringent regulations concerning food safety have driven the adoption of dPCR and qPCR in European nations. Rapidly growing economies in the APAC region, particularly China and India, are investing in their healthcare infrastructure to tackle the rising incidences of disease outbreaks and epidemics. Growing awareness about advanced molecular diagnostic platforms such as dPCR/qPCR among researchers, coupled with their increasing affordability, has contributed significantly towards their acceptance across the APAC region.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the dPCR & qPCR Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising prevalence of infectious diseases and genetic disorders
  • Increasing usage of dPCR and qPCR for efficient delivery of personalized medicine
  • Improving adoption in food testing procedures to ensure safety and consumption

Market Restraints

  • High cost associated with dPCR and qPCR

Market Opportunities

  • Technological advancements in PCR technologies
  • Growing funding for genomics research projects worldwide

Market Challenges

  • Technical limitations and data analysis complexities associated with dPCR and qPCR techniques

Market Segmentation Analysis

  • Product: Expanding presence of sophisticated PCR instruments for rapid detection of genetic sequences
  • Application: Utilization of dPCR and qPCR in clinical applications for infection monitoring and detection
  • End-user: Rising focus of academic research and academic institutes toward PCR technologies

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the dPCR & qPCR Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the dPCR & qPCR Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

QIAGEN Expands Range of Digital PCR Kits and Services for the Biopharma Industry

QIAGEN is expanding its range of digital PCR (dPCR) kits and services for the biopharma industry. The new kits consist of a comprehensive portfolio of ready-to-use assays, reagents, and optimized protocols for high-throughput applications in drug development. They have been specifically designed to enhance data accuracy, sensitivity, reproducibility, and economic feasibility in various fields such as biology, genetics, and cancer research.

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Virax Biolabs Group Limited (Virax) announced an agreement for the distribution of Marburg Virus PCR testing kits. These kits are designed using real-time PCR technology and are capable of detecting RNA from the Marburg Virus.Given the highly virulent nature of Marburg Virus Disease, it is crucial to have accurate and reliable test kits to ensure optimal outcomes for affected individuals and to protect public health.

Thermo Fisher Scientific Launches New Digital PCR Automation Solution

Thermo Fisher Scientific introduced a cutting-edge automation solution for Digital PCR (dPCR) and quantitative PCR (qPCR) experiments. This innovative solution is specifically designed to enhance the accuracy, precision, and sensitivity of qPCR experiments, providing researchers with unparalleled results. The automated workstation included in the solution allows for the simultaneous processing of up to 48 samples, providing efficient and streamlined workflows. Additionally, the software-controlled temperature optimization and semi-automated reagent dispensing features ensure user convenience and ease of use.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the dPCR & qPCR Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the dPCR & qPCR Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Abbott Laboratories, accela s.r.o., Agilent Technologies, Inc., Analytik Jena GmbH, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., BioMed Central Ltd, BioMérieux S.A., Canopy Biosciences, LLC, Combinati Inc., Danaher Corporation, F. Hoffman-La Roche Ltd., GE Healthcare Inc., JN Medsys Pte. Ltd., Merck KGaA, PerkinElmer, Inc., Pfizer Inc., Promega Corporation, QIAGEN N.V. by Thermo Fisher Scientific, Inc., Roche Holding AG, Siemens Healthineers AG, Stilla Technologies SA, Takara Bio Inc., and Vela Diagnostics.

Market Segmentation & Coverage

This research report categorizes the dPCR & qPCR Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Instruments
  • Reagents & Consumables
  • Software & Services
  • Application

Clinical Application

  • Blood Screening
  • Oncology Testing
  • Pathogen Testing
  • Forensic Applications
  • Research Application

End-User

  • Academic Research & Institutes
  • Contract Research Organizations
  • Hospitals & Care Providers
  • Pharmaceutical & Biotechnology Companies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: The recorded online access option does not include the preconference workshop.

The recorded online access option does not include the pre-conference workshop.

Please note: 10% free customization equates to up to 3 hours of analyst time. 

Please note: 10% free customization equates to up to 3 hours of analyst time. 

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of infectious diseases and genetic disorders
5.1.1.2. Increasing usage of dPCR and qPCR for efficient delivery of personalized medicine
5.1.1.3. Improving adoption in food testing procedures to ensure safety and consumption
5.1.2. Restraints
5.1.2.1. High cost associated with dPCR and qPCR
5.1.3. Opportunities
5.1.3.1. Technological advancements in PCR technologies
5.1.3.2. Growing funding for genomics research projects worldwide
5.1.4. Challenges
5.1.4.1. Technical limitations and data analysis complexities associated with dPCR and qPCR techniques
5.2. Market Segmentation Analysis
5.2.1. Product: Expanding presence of sophisticated PCR instruments for rapid detection of genetic sequences
5.2.2. Application: Utilization of dPCR and qPCR in clinical applications for infection monitoring and detection
5.2.3. End-user: Rising focus of academic research and academic institutes toward PCR technologies
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. dPCR & qPCR Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents & Consumables
6.4. Software & Services
7. dPCR & qPCR Market, by Application
7.1. Introduction
7.2. Clinical Application
7.3. Forensic Applications
7.4. Research Application
8. dPCR & qPCR Market, by End-User
8.1. Introduction
8.2. Academic Research & Institutes
8.3. Contract Research Organizations
8.4. Hospitals & Care Providers
8.5. Pharmaceutical & Biotechnology Companies
9. Americas dPCR & qPCR Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific dPCR & qPCR Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa dPCR & qPCR Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. QIAGEN Expands Range of Digital PCR Kits and Services for the Biopharma Industry
12.3.2. Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
12.3.3. Thermo Fisher Scientific Launches New Digital PCR Automation Solution
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. DPCR & QPCR MARKET RESEARCH PROCESS
FIGURE 2. DPCR & QPCR MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DPCR & QPCR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DPCR & QPCR MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DPCR & QPCR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DPCR & QPCR MARKET DYNAMICS
FIGURE 7. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DPCR & QPCR MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. DPCR & QPCR MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DPCR & QPCR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DPCR & QPCR MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DPCR & QPCR MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DPCR & QPCR MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DPCR & QPCR MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DPCR & QPCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DPCR & QPCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DPCR & QPCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DPCR & QPCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DPCR & QPCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DPCR & QPCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DPCR & QPCR MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DPCR & QPCR MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DPCR & QPCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DPCR & QPCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DPCR & QPCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DPCR & QPCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DPCR & QPCR MARKET SIZE, BY FORENSIC APPLICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DPCR & QPCR MARKET SIZE, BY FORENSIC APPLICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DPCR & QPCR MARKET SIZE, BY RESEARCH APPLICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DPCR & QPCR MARKET SIZE, BY RESEARCH APPLICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL DPCR & QPCR MARKET SIZE, BY ACADEMIC RESEARCH & INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL DPCR & QPCR MARKET SIZE, BY ACADEMIC RESEARCH & INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL DPCR & QPCR MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL DPCR & QPCR MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL DPCR & QPCR MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL DPCR & QPCR MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL DPCR & QPCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL DPCR & QPCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. CANADA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. CANADA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. CANADA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. CANADA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. CANADA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. CANADA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. CANADA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 74. CANADA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 75. MEXICO DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 76. MEXICO DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 77. MEXICO DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. MEXICO DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. MEXICO DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. MEXICO DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. MEXICO DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. MEXICO DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. CHINA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 112. CHINA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 113. CHINA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. CHINA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. CHINA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. CHINA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. CHINA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. CHINA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. INDIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. INDIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. INDIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. INDIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. INDIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. INDIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. INDIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 126. INDIA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. JAPAN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. JAPAN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. JAPAN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. JAPAN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. JAPAN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. JAPAN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. JAPAN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. JAPAN DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. THAILAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. THAILAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. THAILAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. THAILAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. THAILAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. THAILAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. THAILAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. THAILAND DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 209. DENMARK DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 210. DENMARK DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 211. DENMARK DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. DENMARK DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. DENMARK DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. DENMARK DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. DENMARK DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. DENMARK DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. EGYPT DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. EGYPT DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. EGYPT DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. EGYPT DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. EGYPT DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. EGYPT DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. EGYPT DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 224. EGYPT DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 225. FINLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 226. FINLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 227. FINLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. FINLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. FINLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. FINLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. FINLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. FINLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. FRANCE DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 234. FRANCE DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 235. FRANCE DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. FRANCE DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. FRANCE DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. FRANCE DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. FRANCE DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. FRANCE DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. GERMANY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. GERMANY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. GERMANY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. GERMANY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. GERMANY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. GERMANY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. GERMANY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 248. GERMANY DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. ITALY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 258. ITALY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 259. ITALY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. ITALY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. ITALY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. ITALY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. ITALY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. ITALY DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 281. NORWAY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 282. NORWAY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 283. NORWAY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. NORWAY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. NORWAY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. NORWAY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. NORWAY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. NORWAY DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. POLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 290. POLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 291. POLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. POLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. POLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. POLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. POLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 296. POLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 297. QATAR DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 298. QATAR DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 299. QATAR DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. QATAR DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. QATAR DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. QATAR DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. QATAR DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 304. QATAR DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 329. SPAIN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 330. SPAIN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 331. SPAIN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 332. SPAIN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 333. SPAIN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 334. SPAIN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 335. SPAIN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 336. SPAIN DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 341. SWEDEN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 342. SWEDEN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 343. SWEDEN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 344. SWEDEN DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 345. SWITZERLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 346. SWITZERLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 349. SWITZERLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 350. SWITZERLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 351. SWITZERLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 352. SWITZERLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 353. TURKEY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 354. TURKEY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 355. TURKEY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 356. TURKEY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 357. TURKEY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 358. TURKEY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 359. TURKEY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 360. TURKEY DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 365. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 366. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 367. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 368. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 369. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 370. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 371. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 372. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 373. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2023 (USD MILLION)
TABLE 374. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2024-2030 (USD MILLION)
TABLE 375. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 376. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 377. DPCR & QPCR MARKET SHARE, BY KEY PLAYER, 2023
TABLE 378. DPCR & QPCR MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 10x Genomics, Inc.
  • Abbott Laboratories
  • accela s.r.o.
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMed Central Ltd
  • BioMérieux S.A.
  • Canopy Biosciences, LLC
  • Combinati Inc.
  • Danaher Corporation
  • F. Hoffman-La Roche Ltd.
  • GE Healthcare Inc.
  • JN Medsys Pte. Ltd.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Pfizer Inc.
  • Promega Corporation
  • QIAGEN N.V. by Thermo Fisher Scientific, Inc.
  • Roche Holding AG
  • Siemens Healthineers AG
  • Stilla Technologies SA
  • Takara Bio Inc.
  • Vela Diagnostics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.88 Billion
Forecasted Market Value ( USD ) by 2030 $ 15.94 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal

Related Topics

Related Reports

Global Digital PCR Market / Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share & Trends by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (Infectious, Oncology), Research, Forensic, Environmental) - Forecast to 2029 - Product Image

Global Digital PCR Market / Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share & Trends by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (Infectious, Oncology), Research, Forensic, Environmental) - Forecast to 2029

  • Report
  • 599 Pages
  • Global
From
Global Real-time PCR, Digital PCR, and End-point PCR Market Size, Share & Trends Analysis Report by Technology (Quantitative, Digital, End-point), Product, Application, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Real-time PCR, Digital PCR, and End-point PCR Market Size, Share & Trends Analysis Report by Technology (Quantitative, Digital, End-point), Product, Application, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
dPCR and qPCR Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Product, Application, End User, and Geography - Product Image

dPCR and qPCR Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Product, Application, End User, and Geography

  • Report
  • 159 Pages
  • Global
From
qPCR and dPCR Instrumentation - Global Strategic Business Report - Product Image

qPCR and dPCR Instrumentation - Global Strategic Business Report

  • Report
  • 573 Pages
  • Global
From
dPCR and qPCR Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

dPCR and qPCR Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.